Since FOXA1 contributes to the establishment of enhancer elements that are subsequently used by transcription factors such as ER in these breast cancer cells, we integrated the MLL3, FOXA1, and GRHL2 ChIP-seq data with ER binding information. This evidence concerns the gene FOXA1 and breast carcinoma.